Biocracked
←

#semaglutide

4 articles
Approach: 3, the human outcome, here as an animal-science moment. Palette: C, natural.

An old female lab mouse with slightly greying, ruffled fur sits upright on a researcher's open gloved palm, photographed at eye level in a close side-on view with a shallow depth of field. Behind it, a softly blurred animal facility window pours in real morning daylight, giving the scene a pale green-grey and warm-wood setting. The nitrile glove is a vivid electric green (#00e676), the single saturated accent. The mouse's whiskers and pink ears catch the light, and the researcher's white coat sleeve is just visible. Tones are natural: skin, soft cream bedding, sage walls. The mood is calm, careful and quietly hopeful, and it conveys age and care rather than drama. The image has no text, no labels and no readable writing.
longevity

Aktivna komponenta Ozempica produžila je životni vijek kod starijih miševa – evo zašto

BY DR. SYNAPSE ·

Semaglutid, aktivna komponenta u preparatima Ozempic i Wegovy, produžio je životni vijek kod starijih ženki miševa u novoj studiji objavljenoj u časopisu *Nature* uz suradnju istraživača s UC Berkeleyja. Liječenje je započelo u dobi od 20 mjeseci i oponašalo je mnoge učinke restrikcije kalorija. U izravnoj usporedbi lijek je pokazao povoljnije rezultate od odgovarajuće restrikcije kalorija u području istraživačke motivacije, prostorne memorije i regulacije glukoze. Ipak, radi se o studiji na miševima, isključivo na ženama, i ne pruža smjernice o dozi za ljude. Evo što nalazi sugeriraju, a što ne.

Approach: Macro science, the human outcome angle through tissue. Palette: D, bold color field.

Extreme close-up of a cross-section of raw beef thigh muscle, used as a stand-in for human thigh tissue. It is shot straight on and slightly from above, on a saturated tomato-red seamless backdrop. Fine white fat marbling threads run through the dark red muscle fibers. On one half the marbling is dense and lacy, and on the other it is sparse and clean, so the contrast reads as a before and after. A thin, translucent calipers-style steel ruler lies along the edge, with no markings readable. Lighting is soft, directional studio light from the upper left, with crisp highlights on the glistening fibers and gentle warm shadows. A single small electric green surgical marker dot sits on the tissue. The mood is analytical, tense and uncertain, with shallow depth of field and sharp detail on the fat texture.
longevity

Visokodozirani semaglutid i mišići bedara: što MRI pokazuje

BY HELIX WARD ·

Novi MRI pod‑analiza STEP UP studije ispitala je što 72 tjedna visokodoziranog semaglutida (7,2 mg) čini s tjelesnim sastavom, uključujući mišiće bedara. Gubitak masnoće bio je velik, oko 11 L u odnosu na placebo, a infiltracija masnoće u mišiću bedara značajno je opala. Volumen mišića bedara smanjio se za otprilike 1,1 L – promjena koja nije dosegnula statističku značajnost (p = 0,07), ali interval pouzdanosti pokazuje nagib prema gubitku. S jedino 55 skeniranih sudionika, od čega je šest bilo na placebo, te uz sudjelovanje Novo Nordiska, rezultati su sugestivni, a ne konačni. Evo što podaci pokazuju, što ne mogu pokazati i kako zaštititi mišiće na GLP‑1 terapiji.

**Approach:** Lab in action. **Palette:** Bold color field, mustard yellow.

A close, slightly high three-quarter view of a hand in a magenta-purple nitrile glove holding a clear 12-well cell culture plate. Each well is filled with salmon-pink culture medium. A multichannel pipette hovers over one well, with a single droplet caught just before it falls. The background is a seamless, saturated mustard-yellow surface and wall, with a soft shadow under the plate. Bright, even studio light comes from the upper left, giving crisp highlights on the plastic rims and a soft glow through the liquid. The depth of field is shallow, so the far wells blur gently. A tiny electric-green cap on a tube sits in the corner of the frame. The mood is calm, precise and curious, with a clean, graphic, editorial feel. No text or labels.
peptides

Semaglutid nije smanjio ljudske mišićne stanice. Pa zašto dolazi do gubitka mišića?

BY DR. SYNAPSE ·

Je li semaglutid zaista “jede” vaše mišiće? Nova studija u *GeroScience* izložila je lijek izravno primarnim ljudskim mišićnim stanicama starijih osoba s pretilošću, a stanice nisu pokazale atrofu. Nijedan gen za atrofiju se nije aktivirao, nije bilo alarma u sekretnom proteomu, a GIP je čak povećao debljinu miofibrila nakon osam dana. Semaglutid je blago smanjio glikolitičku proizvodnju ATP‑a, a GLP‑1 receptori su bili jedva detektabilni. Rezultati ukazuju na indirektne uzroke gubitka mišićne mase, poput kalorijskog deficita i smanjenog opterećenja, iako tanjur nije mišić.

**Approach: Conceptual metaphor. Palette: D, bold color field.**

A single clear glass of water sits on a saturated mustard-yellow backdrop, shot at a slight low three-quarter angle. A hand-held pen injector rests beside it, its body a matte white with a small electric green dial ring as the only green accent. Hard but clean studio light from the upper left throws a crisp, defined shadow across the yellow surface. Through the glass, the injector is refracted into two slightly offset images, suggesting a signal that is split and hard to read. The mood is calm, questioning and balanced, with no drama. The background is fully warm and bright, with no blue cast. The surface has a subtle paper-like texture. There is no text, no label and no face.
metabolism

Uzrokuju li Ozempic i Mounjaro depresiju? Što je otkrilo 20 studija

BY DR. SYNAPSE ·

Povezuju li se Ozempic i Mounjaro s depresijom ili suicidalnim mislima? Najnoviji sustavni pregled 20 studija, uz procjene EMA‑e i FDA‑e, pokazuje da najbolji podaci ne potvrđuju takvu vezu. Randomizirani podaci, uključujući dva velika meta‑analize iz 2025., nisu otkrili povećani rizik od samoubojstva, depresije ili anksioznosti uz semaglutid ili tirzepatid. Alarmantni signali potekli su iz studija koje ne mogu odvojiti učinak lijeka od stresa povezanog s pretilošću, osnovnog psihijatrijskog rizika i pristranosti u izvještavanju. Ipak, klinička ispitivanja isključivala su mnoge psihijatrijske pacijente, pa je daljnje praćenje i dalje važno za rizične skupine i rijetke dugoročne ishode.

This page is available in